Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System - New Operating System Offers Health Systems Long-Term Medication Management Platform and Enhanced Cybersecurity - CareFusion.com / BD.com
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System

 

PRZOOM - /newswire/ - Franklin Lakes, NJ, United States, 2016/12/01 - New Operating System Offers Health Systems Long-Term Medication Management Platform and Enhanced Cybersecurity - CareFusion.com / BD.com. NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced adoption of Windows 10 Internet of Things (IoT) operating system (OS) for its enterprise-wide Pyxis™ ES System. The new OS provides long-term support and enhanced cybersecurity for health systems’ automated dispensing and medication management solutions.

Windows 10 IoT in the Long Term Servicing Branch (LTSB) offers a 10-year support package, active security patches and options to upgrade when Microsoft offers new OS features every two to three years. Extending the life-cycle of the OS will be an important enabler as BD transforms from hardware-based product upgrade cycles to more dynamic software-based innovations and technology enhancements for continuous improvement in usability and performance.

“This specific OS design was requested and championed by BD in collaboration with Microsoft and other health care vendors to reduce disruption to our customers that occurs with embedded OS upgrades every four to five years,” said Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD. “With fewer upgrade disruptions and more regular technology advancements, health care providers will enjoy greater focus on their chief objective of improving patient health, while BD drives innovation to enable safer, simpler and more effective medication management -- from medication reconciliation at the pharmacy to medication administration at the bedside -- across the continuum of care. This is the first of many innovations we plan to deliver through our deep collaboration with Microsoft across our feature-rich platforms.”

BD is also engaged in early testing of the Windows Server 2016 and SQL Server 2016 pre-releases in order to ensure Pyxis medication management technologies are consistently updated with the latest, most robust releases of Microsoft technologies.

“Microsoft is committed to advancing the Internet-of-Things by collaborating with industry leaders like BD to help them provide the most comprehensive medication management technology for the global health care market,” said Doug Smith, senior director of product marketing, Windows, Microsoft Corp. “Adding Windows 10 IoT to the Pyxis™ ES System ensures a longer lifecycle for medication management connected devices and provides greater stability, fewer upgrades and customer disruptions while still keeping devices updated with state-of-art security and the newest technology features. This is a great example of how our longstanding collaboration with BD has allowed us deep insights into the needs of health organizations and how best to support enterprise-wide connected solutions with Microsoft technologies.”

Visit carefusion.com/pyxis for more information about Pyxis Enterprise medication management solutions.

About BD
BD (bd.com) is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.

BD Contact: Monique N. Dolecki - BD Investor Relations
P: 201 847 5378 - E: monique_dolecki[.]bd.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Pyxis™ ES System | BD
Contact: Matthew Coppola - BD.com 
201-847-7370 matthew_r_coppola[.]bd.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Becton, Dickinson and Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen to Present 12 Abstracts At the 11th World Congress for Neurorehabilitation (WCNR) Virtual Congress
Imec Announces elPrep5 - the Newest Version of its Software Platform for DNA Analysis
Ipsen Showcases Commitment to Patient-centric Advances in Oncology with Record Number of Abstracts to be Presented At ESMO 2020 Virtual Congress
Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Announced
Ipsen to Present New Insights At ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen to Present Results from MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP) At ASBMR 2020 Annual Meeting
DSM Ignites New Strategic Initiative to Transform Global Animal Nutrition and Health
Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market
DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Garrison Minerals, LLC

Visit  RightITnow, Inc.

Visit  BizJobs.com







 
  ©2020 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today